FARMACIA HOSPITALARIA
vvIQ30al7F4
vvIQ30al7F4
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Manejo seguro de Medicamentos Peligrosos en las organizaciones sanitarias <br />
BIBLIOGRAFÍA<br />
• (1) ASHP technical assistance bulletin on handling cytotoxic<br />
and hazardour drugs. Review. Am J Hosp Pharm<br />
1990; 47 (5):1033-49.<br />
• (2) Occupational Safety and Health Administration<br />
(OSHA) https://www.osha.gov/SLTC/hazardousdrugs/<br />
• (3) NIOSH [2004]. NIOSH alert: preventing occupational<br />
exposure to antineoplastic and other hazardous<br />
drugs in health care settings. U.S. Department of Health<br />
and Human Services, Public Health Service, Centers<br />
for Disease Control and Prevention, National Institute<br />
for Occupational Safety and Health, DHHS (NIOSH)<br />
Publication No. 2004-165. http://www.cdc.gov/niosh/<br />
docs/2004-165/pdfs/2004-165.pdf<br />
• (4) NIOSH List of Antineoplastic and Other Hazardous<br />
Drugs in Healthcare Settings 2010 DHHS (NIOSH) Publication<br />
No. 2010-167 (September 2010).<br />
• (5) NIOSH List of Antineoplastic and Other Hazardous<br />
Drugs in Healthcare Settings 2012 DHHS (NIOSH) Publication<br />
No. 2012-150 (June 2012).<br />
• (6) NIOSH List of Antineoplastic and Other Hazardous<br />
Drugs in Healthcare Settings, 2014. http://www.cdc.<br />
gov/niosh/docs/2014-138/pdfs/2014-138.pdf<br />
• (7) NIOSH 2016. List of Antineoplastic and Other<br />
Hazardous Drugs in Healthcare Settings. 2016. https://<br />
www.cdc.gov/niosh/topics/antineoplastic/pdf/hazardous-drugs-list_2016-161.pdf<br />
• (8) Documento Técnico Medicamentos peligrosos.<br />
Medidas de prevención para su preparación y administración.<br />
Instituto Nacional de Seguridad e Higiene en el<br />
Trabajo (INSHT) del Ministerio de Empresa y Seguridad<br />
Social. Septiembre 2016.<br />
• (9) Falck K, et al. Mutagenicity in urine of nurses handling<br />
cytostatic drugs. Lancet. 1979 Jun 9;1 (8128):1250-1251.<br />
• (10) Nguyen TV, Theiss JC, Matney TS. Exposure of<br />
pharmacy personnel to mutagenic antineoplastic drugs.<br />
Cancer Res. 1982 Nov;42 (11):4792-4796.<br />
• (11) Harris CC. The carcinogenicity of anticancer drugs: a<br />
hazard in man. Cancer. 1976 Feb;37 (2 Suppl):1014-1023.<br />
• (12) Gallelli JF. Issues and risks associated with handling<br />
antineoplastic drugs. J Pharm Pract. 1991 Feb;IV (1):72-<br />
76.<br />
• (13) Centers for Disease Control and Prevention (CDC).<br />
Hazardous Drug Exposure in Healthcare. (Updated: Mar<br />
16, 2016.) Accessed Mar 18, 2016. http://www.cdc.gov/<br />
niosh/topics/hazdrug/<br />
• (14) Sessink PJ, et al. Cancer risk assessment for health<br />
care workers occupationally exposed to cyclophosphamide.<br />
Int Arch Occup Environ Health. 1995;67 (5):317-<br />
323.<br />
• (15) Zhao SF, et al. The effects of occupational exposure<br />
of female nurses to antineoplastic drugs on pregnancy<br />
outcome and embryonic development. Teratology.<br />
1996;53 (2):94.<br />
• (16) Xie J, et al. An epidemiological study of the effect<br />
of occupational exposure to antineoplastic drugs on<br />
reproductive outcomes in nurses. Chin J Ind Hyg Occup<br />
Dis. 2001 Apr;19:87-90.<br />
• (17) Sessink PJ, et al. Environmental contamination and<br />
assessment of exposure to antineoplastic agents by<br />
determination of cyclophosphamide in urine of exposed<br />
pharmacy technicians: is skin absorption an important<br />
exposure route? Arch Environ Health. 1994 May-Jun;49<br />
(3):165-169.<br />
• (18) Miller, SA, Dodd, M, Goodman, MS et al, Cancer<br />
chemotherapy: Guidelines and recommendations for<br />
nursing education and practice. Oncology Nursing Society,<br />
Pittsburgh; 1984.<br />
• (19) US Department of Labor. Office of Occupational<br />
Medicine: Occupational Safety and Health Administration:<br />
Work practice guidelines for personnel dealing<br />
with cytotoxic (antineoplastic) drugs. Publication No.<br />
8-1.1. 1986.<br />
• (20) ASHP Guidelines on Handling Hazardous Drugs.<br />
ASHP bulletin, 1990. https://www.ashp.org/doclibrary/<br />
bestpractices/prepgdlhazdrugs.aspx<br />
• (21) General Chapter Hazardous Drugs—Handling<br />
in Healthcare Settings. United States Pharmacopeia.<br />
USP 2016 http://www.usp.org/usp-nf/notices/general-chapter-hazardous-drugs-handling-healthcare-settings<br />
• (22) General Chapter Pharmaceutical Compounding-Sterile<br />
Preparations United States Pharmacopeia.<br />
http://www.usp.org/usp-nf/notices/general-chapter-797-proposed-revision<br />
• (23) General Chapter Pharmaceutical Compounding-<br />
Non sterile Preparations United States Pharmacopeia.<br />
http://www.usp.org/es/usp-nf/official-text/<br />
revision-bulletins/pharmaceutical-compounding-nonsterile-preparations<br />
• (24) Beatriz G García-Alcántara, Catalina Perelló Alomar,<br />
Elena Moreno Centeno, Pilar Modamio, Eduardo L Mariño,<br />
Olga Delgado Sánchez. Impacto de las nuevas recomendaciones<br />
de manipulación de Medicamentos Peligrosos<br />
en un Servicio de Farmacia. Farm Hosp (en prensa).<br />
claves de 2017 79
Change language